Rebecca Leary
Lab Head & Director, Next-Generation Diagnostics Novartis
Rebecca is a Director in Oncology Translational Research at Novartis BioMedical Research in Cambridge, Massachusetts. She leads biomarker and translational research that integrates liquid biopsy approaches, and other advanced exploratory platforms, to accelerate oncology drug discovery and clinical development.
Rebecca received her Ph.D. in Cellular and Molecular Medicine from the Johns Hopkins University School of Medicine, completed postdoctoral training at the Ludwig Center for Cancer Genetics and Therapeutics at Johns Hopkins, and earned her bachelor’s degree in Biological Sciences from Wellesley College.
Seminars
Wednesday 22nd July 2026
Accelerating Clinical Development with ctDNA Clearance & Multi-Omic Profiling
8:30 am
- Using ctDNA clearance timepoints to optimize dose selection and accelerate internal go or no-go decisions across modalities under Project Optimus
- Expanding beyond mutation profiling through multi-omic approaches to better track resistance, cell surface targets, and combination strategy rationale
- Advancing standardization and regulatory alignment for complex assays throughcollaborative initiatives such as BLOODPAC
